$0.395
-0.0249[-5.93%]
Last update: 9:26AM Get Real Time Here
NeuBase Therapeutics
(NASDAQ:NBSE)NeuBase Therapeutics Stock (NASDAQ:NBSE), Earnings Estimates, EPS, and Revenue
NeuBase Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 9
EPS
$-0.660
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of NeuBase Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | PM | NBSE | Q2 | -$2.40 | — | — | — | $0.00 | — | — | — | Get Alert |
| 04/30/2024 | PM | NBSE | Q1 | -$2.60 | — | — | — | $0.00 | — | — | — | Get Alert |
| 11/09/2023 | AM | NBSE | Q4 | -$4.80 | -$0.97 | -$0.66 | 31.96% | $0.00 | — | $0.00 | — | Get Alert |
| 08/14/2023 | PM | NBSE | Q3 | -$5.20 | — | -$2.04 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/11/2023 | PM | NBSE | Q2 | -$6.00 | -$2.20 | -$2.40 | -9.09% | $0.00 | — | $0.00 | — | Get Alert |
| 02/14/2023 | PM | NBSE | Q1 | -$4.80 | -$4.00 | -$2.60 | 35.00% | $0.00 | — | $0.00 | — | Get Alert |
| 12/21/2022 | AM | NBSE | Q4 | -$4.20 | — | -$4.80 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/11/2022 | PM | NBSE | Q3 | -$5.80 | — | -$5.20 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/12/2022 | PM | NBSE | Q2 | -$4.80 | — | -$6.00 | — | $0.00 | — | $0.00 | — | Get Alert |
| 02/10/2022 | PM | NBSE | Q1 | -$3.60 | -$4.60 | -$4.80 | -4.35% | $0.00 | — | $0.00 | — | Get Alert |
| 12/23/2021 | PM | NBSE | Q4 | -$4.00 | -$4.60 | -$4.20 | 8.70% | $0.00 | — | $0.00 | — | Get Alert |
| 08/12/2021 | PM | NBSE | Q3 | -$3.60 | -$4.20 | -$5.80 | -38.10% | $0.00 | — | $0.00 | — | Get Alert |
| 05/13/2021 | PM | NBSE | Q2 | -$5.20 | -$4.40 | -$4.80 | -9.09% | $0.00 | — | $0.00 | — | Get Alert |
| 02/11/2021 | PM | NBSE | Q1 | -$5.20 | — | -$3.60 | — | $0.00 | — | $0.00 | — | Get Alert |
| 12/23/2020 | PM | NBSE | FY | -$9.00 | -$4.60 | — | — | $0.00 | — | — | — | Get Alert |
| 12/23/2020 | PM | NBSE | Q4 | — | — | -$4.00 | — | — | — | $0.00 | — | Get Alert |
| 08/13/2020 | PM | NBSE | Q3 | -$7.60 | — | -$3.60 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/14/2020 | PM | NBSE | Q2 | -$6.60 | — | -$5.20 | — | — | — | $0.00 | — | Get Alert |
| 03/26/2020 | PM | NBSE | Q1 | — | -$6.40 | -$5.20 | 18.75% | — | — | $0.00 | — | Get Alert |
FAQ
When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?
NeuBase Therapeutics (NBSE) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on November 9, 2023 for Q4.
What were the latest earnings per share (EPS) for NeuBase Therapeutics (NASDAQ:NBSE)?
The Actual EPS was $-0.66, which beat the estimate of $-0.97.
What were NeuBase Therapeutics’s (NASDAQ:NBSE) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.